Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

468.10 -9.22 (-1.93%)
Streaming Delayed Price Updated: 10:30 AM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
71 72 Next >
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
4 No-Brainer Stocks to Buy Right Now ↗
Via The Motley Fool
News headline image
Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex... 
Via StockStory
Topics Artificial Intelligence
News headline image
Top S&P500 movers in Wednesday's session ↗
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
News headline image
Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip ↗
Via The Motley Fool
Topics Earnings Intellectual Property Law Enforcement
News headline image
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN) ↗
Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves. 
Via Chartmill
News headline image
1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
News headline image
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday? ↗
Vertex posted Q1 EPS and sales below estimates but raised its 2025 revenue outlook, driven by CF drug demand and new product launches in the U.S. 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
News headline image
Why Vertex Pharmaceuticals Stock Is Sinking Today ↗
Via The Motley Fool
News headline image
Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday? ↗
Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of Wednesday’s Federal Reserve meeting. 
Via Benzinga
Topics Economy
News headline image
Which S&P500 stocks are gapping on Tuesday? ↗
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Tuesday to find the gap up and gap down stocks in today's session. 
Via Chartmill
News headline image
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks ↗
The company paused a study of a cystic fibrosis treatment, right on the heels of a scrapped type 1 diabetes program. 
Via Investor's Business Daily
Topics Government Intellectual Property
News headline image
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
Rising Costs Weigh on Vertex Q1 Earnings ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Wondering what's happening in today's S&P500 pre-market session? ↗
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
This Vertex Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss ↗
The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline. 
Via Stocktwits
Topics World Trade
News headline image
Monday's after hours session: top gainers and losers in the S&P500 index ↗
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top S&P500 gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance ↗
Vertex Pharmaceuticals reports first-quarter financial results after the market close on Monday. Here's a look at the key highlights from the period. 
Via Benzinga
News headline image
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of... 
Via StockStory
News headline image
Vertex Reports First Quarter 2025 Financial Results
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum? ↗
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. Stock up 25.48% in past year, charts show bullish trend. 
Via Benzinga
News headline image
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday? ↗
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services... 
Via Benzinga
News headline image
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
 
Via Benzinga
News headline image
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now ↗
Now may be a smart time to buy small stakes in these fundamentally robust companies. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
3 No-Brainer Stocks to Buy in May ↗
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
71 72 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.